Antimicrobial drug use in hospitals in the Netherlands, Germany and Belgium
- 1 November 1993
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 12 (11), 832-838
- https://doi.org/10.1007/bf02000403
Abstract
Data on the use of antimicrobial drugs was collected by means of an inquiry to 30 hospitals in Belgium (15 in Dutch sectors and 15 in the French sectors), 21 hospitals in Germany and 20 hospitals in the Netherlands. The use of these drugs was expressed as the number of defined daily doses (DDD) per 100 bed days by the anatomical therapeutical chemical classification system. The total use of antimicrobial agents was significantly (p<0.001) higher in both parts of Belgium (55.6 and 52.0 DDD per 100 bed days) than in Germany (37.9 DDD) or the Netherlands (34.1 DDD). In particular, amoxicillin-clavulanic acid, the first- and second-generation cephalosporins, aminoglycosides and fluoroquinolones were used more in Belgium than in either of the other countries. At least part of the differences observed in antimicrobial drug use could be explained by differences in written antibiotic policy.Keywords
This publication has 7 references indexed in Scilit:
- Therapeutic and epidemiologic recommendations to reduce the spread of type-I beta-lactamase resistance.1992
- Incidence of multi-resistant gram-negative isolates in eight Dutch hospitals. The 1990 Dutch Surveillance Study.1991
- Incidence of multi-resistance in gram-negative bacterial isolates from intensive care units in Belgium: a surveillance study.1991
- Susceptibility to beta-lactam antibiotics in septicemia isolates from twenty-nine European laboratoriesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- Resistance of gram-negative bacilli as related to hospital use of antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- Statistics at square one. XII--The t tests (continued).BMJ, 1976
- XI--The t tests.BMJ, 1976